induct 发表于 2025-3-28 16:01:52

http://reply.papertrans.cn/19/1879/187814/187814_41.png

enflame 发表于 2025-3-28 21:36:27

http://reply.papertrans.cn/19/1879/187814/187814_42.png

chronicle 发表于 2025-3-28 23:18:31

http://reply.papertrans.cn/19/1879/187814/187814_43.png

六个才偏离 发表于 2025-3-29 05:15:32

http://reply.papertrans.cn/19/1879/187814/187814_44.png

Evacuate 发表于 2025-3-29 09:17:51

http://reply.papertrans.cn/19/1879/187814/187814_45.png

好色 发表于 2025-3-29 13:37:36

http://reply.papertrans.cn/19/1879/187814/187814_46.png

全等 发表于 2025-3-29 17:39:47

http://reply.papertrans.cn/19/1879/187814/187814_47.png

赔偿 发表于 2025-3-29 20:22:55

Die Revaskularisation der A. iliaca internatubular injury than creatinine especially with its isoenzymes and when combined with other renal biomarkers, for example, NGAL and Kim-1. .-Acetyl-β-.-glucosaminidase is stable in urine, and the variation among individuals is minimal that the spot urine sample is adequate for the assay practically w

ALLAY 发表于 2025-3-30 02:49:46

Biomarkers in Kidney Transplantationof biomarkers. This review is focused on recently developed biomarkers in acute rejection and tolerance as the two most important processes in decision-making about immunosuppressive therapy. The clinical utilities and limitations of these markers are discussed in details.

软弱 发表于 2025-3-30 06:08:37

Peritoneal Effluent Biomarker Discovery in Peritoneal Dialysis: The Omics Erateomics with the peritoneal effluent as biospecimen is however still in its infancy..The emerging field of omics techniques as tools for peritoneal effluent biomarker discovery is presented in this chapter. The high sensitivity of omics technologies requires stringent conditions, and therefore metho
页: 1 2 3 4 [5] 6
查看完整版本: Titlebook: Biomarkers in Kidney Disease; Vinood B. Patel,Victor R. Preedy Reference work 2016 Springer Science+Business Media Dordrecht 2016 Applicat